PF0713

PF0713
Clinical data
Drug classGABAA receptor positive allosteric modulator; Anesthetic
Identifiers
  • 2,6-bis[(2R)-butan-2-yl]phenol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC14H22O
Molar mass206.329 g·mol−1
3D model (JSmol)
  • CC[C@@H](C)C1=C(C(=CC=C1)[C@H](C)CC)O
  • InChI=1S/C14H22O/c1-5-10(3)12-8-7-9-13(14(12)15)11(4)6-2/h7-11,15H,5-6H2,1-4H3/t10-,11-/m1/s1
  • Key:FHTGJZOULSYEOB-GHMZBOCLSA-N

PF0713 ((R,R)-2,6-di-sec-butylphenol) is a sedative and anesthetic drug related to propofol. It was first discovered in 1980 as part of the research which led to propofol itself, and was found to be of similar potency but with a longer duration of action than propofol. However, it was only assayed at this time as the racemic mixture of isomers, and the most active (R,R) stereoisomer was not isolated and tested individually until 2009. While the related compound cipepofol was ultimately adopted for clinical use, PF0713 has similarly been researched for potential medical applications, and while it has not been adopted for clinical use, it continues to be used in research.

See also